Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Modus Therapeutics Holding AB (publ)

MODTX.ST

HealthcareSTOSE

SEK 0.481

-SEK 0.002 (-0.41%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

MODTX.ST

1Y-0.003 (-0.62%)

Candles, volume, SMA 20, and SMA 50

O 0.47H 0.487L 0.461C 0.478Date Jun 10

MODTX.ST

SMA 20 SMA 50 Vol 32.93K

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Founded in 2011 and headquartered in Stockholm, Sweden, Modus Therapeutics Holding AB (publ) is a biotechnology firm dedicated to developing treatments for sepsis and septic shock. Its primary product, Sevuparin, a polysaccharide, is presently undergoing Phase Ib clinical evaluation for its potential in treating patients afflicted with these serious conditions.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$43.85M

Volume?867.05K

Avg Volume?997.14K

52w RangeSEK 0.208 - SEK 5.00

Beta?0.38

Price Performance

No historical price data is available for this symbol yet.

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide